The construction of novel CuO/SnO2@g-C3N4 photocatalyst for efficient degradation of ciprofloxacin, methylene blue and photoinhibition of bacteria through efficient production of reactive oxygen species DOI
Irum Batool, Karma Albalawi, Afaq Ullah Khan

et al.

Environmental Research, Journal Year: 2023, Volume and Issue: 231, P. 116086 - 116086

Published: May 9, 2023

Language: Английский

Green and sustainable synthesis of nanomaterials: Recent advancements and limitations DOI
Deepshikha Gupta, Anuj Boora,

Amisha Thakur

et al.

Environmental Research, Journal Year: 2023, Volume and Issue: 231, P. 116316 - 116316

Published: June 1, 2023

Language: Английский

Citations

174

(Nano)platforms in bladder cancer therapy: Challenges and opportunities DOI
Milad Ashrafizadeh, Ali Zarrabi, Hassan Karimi‐Maleh

et al.

Bioengineering & Translational Medicine, Journal Year: 2022, Volume and Issue: 8(1)

Published: June 8, 2022

Urological cancers are among the most common malignancies around world. In particular, bladder cancer severely threatens human health due to its aggressive and heterogeneous nature. Various therapeutic modalities have been considered for treatment of although prognosis remains unfavorable. It is perceived that depends on an interdisciplinary approach combining biology engineering. The nanotechnological approaches introduced in various cancers, especially cancer. current review aims emphasize highlight possible applications nanomedicine eradication tumor. Nanoparticles can improve efficacy drugs therapy through elevating their bioavailability. potential genetic tools such as siRNA miRNA gene expression regulation be boosted using nanostructures by facilitating internalization accumulation at tumor sites cells. provide photodynamic photothermal ROS overgeneration hyperthermia, respectively, suppression Furthermore, remodeling microenvironment infiltration immune cells purpose immunotherapy achieved cargo-loaded nanocarriers. Nanocarriers mainly internalized endocytosis, proper design smart nanoparticles pH-, redox-, light-responsive nanocarriers importance targeted therapy. Bladder biomarkers detected timely diagnosis patients. Based site, they employed imaging. clinical translation challenges also covered review.

Language: Английский

Citations

93

Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges DOI Creative Commons
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi

et al.

Pharmacological Research, Journal Year: 2022, Volume and Issue: 187, P. 106553 - 106553

Published: Nov. 16, 2022

Cancer progression results from activation of various signaling networks. Among these, PI3K/Akt contributes to proliferation, invasion, and inhibition apoptosis. Hepatocellular carcinoma (HCC) is a primary liver cancer with high incidence rate, especially in regions prevalence viral hepatitis infection. Autoimmune disorders, diabetes mellitus, obesity, alcohol consumption, inflammation can also lead initiation development HCC. The treatment HCC depends on the identification oncogenic factors that tumor cells develop resistance therapy. present review article focuses role progression. Activation promotes glucose uptake, favors glycolysis increases cell proliferation. It inhibits both apoptosis autophagy while promoting survival. stimulates epithelial-to-mesenchymal transition (EMT) matrix-metalloproteinase (MMP) expression during metastasis. In addition increasing colony formation capacity facilitating spread cells, angiogenesis. Therefore, silencing prevents aggressive behavior. confer drug resistance, particularly sorafenib, decreases radio-sensitivity cells. Anti-cancer agents, like phytochemicals small molecules suppress by limiting Being upregulated tissues clinical samples, be used as biomarker predict patients' response

Language: Английский

Citations

83

Biomimetic cell membrane‐coated poly(lactic‐ co ‐glycolic acid) nanoparticles for biomedical applications DOI Creative Commons
Nasrullah Jan, Asadullah Madni, Safiullah Khan

et al.

Bioengineering & Translational Medicine, Journal Year: 2022, Volume and Issue: 8(2)

Published: Nov. 2, 2022

Abstract Poly(lactic‐ co ‐glycolic acid) (PLGA) nanoparticles (NPs) are commonly used for drug delivery because of their favored biocompatibility and suitability sustained controlled release. To prolong NP circulation time, enable target‐specific overcome physiological barriers, NPs camouflaged in cell membranes have been developed evaluated to improve delivery. Here, we discuss recent advances membrane‐coated PLGA NPs, preparation methods, application cancer therapy, management inflammation, treatment cardiovascular disease control infection. We address the current challenges highlight future research directions needed effective use membrane‐camouflaged NPs.

Language: Английский

Citations

82

Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis DOI Creative Commons
Afshin Taheriazam,

Ghazaleh Gholamiyan Yousef Abad,

Shima Hajimazdarany

et al.

Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 354, P. 503 - 522

Published: Jan. 20, 2023

Language: Английский

Citations

54

Alginate coated superparamagnetic iron oxide nanoparticles as nanocomposite adsorbents for arsenic removal from aqueous solutions DOI
Somayeh Asadi Haris, Shadab Dabagh, Hamidreza Mollasalehi

et al.

Separation and Purification Technology, Journal Year: 2023, Volume and Issue: 310, P. 123193 - 123193

Published: Jan. 17, 2023

Language: Английский

Citations

50

Enhanced In Vivo Radiotherapy of Breast Cancer Using Gadolinium Oxide and Gold Hybrid Nanoparticles DOI Creative Commons

Hamed Nosrati,

Marziyeh Salehiabar,

Jalil Charmi

et al.

ACS Applied Bio Materials, Journal Year: 2023, Volume and Issue: 6(2), P. 784 - 792

Published: Jan. 24, 2023

Radiation therapy has demonstrated promising effectiveness against several types of cancers. X-ray radiation can be made further effective by utilizing nanoparticles high-atomic-number (high-Z) materials that act as radiosensitizers. Here, in purpose maximizing the within tumors, bovine serum albumin capped gadolinium oxide and gold (Gd2O3@BSA-Au NPs) are developed a bimetallic radiosensitizer. In this study, we incorporate two high-Z-based nanoparticles, Au Gd, single nanoplatform. The radiosensitizing ability was assessed with series vitro tests, following evaluation vivo breast cancer murine model. Enhanced tumor suppression is observed group received after administration Gd2O3@BSA-Au NPs. As result, efficacy significantly improved applying NPs under irradiation, evidenced studies evaluating cell viability, proliferation, reactive oxygen species production, anti-tumor effect.

Language: Английский

Citations

49

Chitosan- and hyaluronic acid-based nanoarchitectures in phototherapy: Combination cancer chemotherapy, immunotherapy and gene therapy DOI
Zheng Wang,

Shuo Pang,

Xiaoli Liu

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 273, P. 132579 - 132579

Published: May 23, 2024

Language: Английский

Citations

35

Recent advances in nanomaterial-based drug delivery systems DOI
Vikram Jadhav, Arpita Roy,

Kirtanjot Kaur

et al.

Nano-Structures & Nano-Objects, Journal Year: 2024, Volume and Issue: 37, P. 101103 - 101103

Published: Feb. 1, 2024

Language: Английский

Citations

23

Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics DOI
Vahid Rahimkhoei,

Asaad H. Alzaidy,

May Jaleel Abed

et al.

Advances in Colloid and Interface Science, Journal Year: 2024, Volume and Issue: 329, P. 103204 - 103204

Published: May 22, 2024

Language: Английский

Citations

21